Risk Factors for Severe Rash With Use of Vemurafenib Alone or in Combination With Cobimetinib for Advanced Melanoma: Pooled Analysis of Clinical Trials

BMC Cancer - United Kingdom
doi 10.1186/s12885-020-6659-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-Treated Patients With BRAFV600-mutated Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Efficacy of Single‐Agent Chemotherapy for Patients With Advanced Invasive Lobular Carcinoma: A Pooled Analysis From Three Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2018English

Nitrone-Based Therapeutics for Neurodegenerative Diseases: Their Use Alone or in Combination With Lanthionines

Free Radical Biology and Medicine
BiochemistryPhysiology
2013English

Targeting Epigenetics for Treatment of BRAF Mutated Metastatic Melanoma With Decitabine in Combination With Vemurafenib: A Phase Lb Study

Oncotarget
Oncology
2017English

SAT0189 Factors Influencing the Prescription of Tocilizumab Alone or in Combination With Dmards in Rheumatoid Arthritis Patients in a Real Life Setting. Pooled Analysis of 3 Observational Studies

2017English

060 Integrated Safety of Ixekizumab in Patients With Moderate-To-Severe Psoriasis: Results From a Pooled Analysis of 7 Clinical Trials

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 Mg/Kg Alone or in Combination With High Dose Interferon-Α2b in Advanced Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Risk Factors for Lentigo Maligna Melanoma Compared With Superficial Spreading Melanoma

Archives of Dermatology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy